EUFEMED webinar 'Phase 1 Vaccine Studies in the Times of Covid-19…'
We invite you for this free EUFEMED webinar.
COVID has highlighted the importance of Phase 1 trials with vaccines. And yet, only a handful of sponsors, Phase 1 sites and investigators have a thorough understanding of the science, methodology, ethics and logistics required to run suchtrials. This New Years EUFEMED webinar will provide you with cutting-edge insight into newest developments around such trials while also learning about the experience of others and providing an opportunity to discuss recommendations.
Schedule of this EUFEMED webinar 'Phase 1 Vaccine Studies in the Times of Covid-19…'
|On Thursday 28 January:|
|16:00 - 16:10||Welcome and introduction|
|16:10 - 16:40||An overview of current vaccine platforms and the development of a new vaccine against SARS-CoV-2 Johan Neyts, Rega Institute, KU Leuven, Belgium Q&A|
|16:40 - 17:10||The challenges of setting up a Phase 1 vaccine trial during the Corona pandemic: The sponsor’s point of view Johan Van Hoof, Janssen Pharmaceutica, Beerse, Belgium Q&A|
|17:10 - 17:30||The challenges of conducting a Phase 1 vaccine trial during the Corona pandemic: The investigator’s point of view Wouter Botermans, Center for Clinical Pharmacology, KU Leuven, Belgium Q&A|
|17:30 - 17:40||General Discussion|
|17:40 - 18:00||Closing remarks|